Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2/ARE pathway in Parkinson's disease.
- DOI
- 10.1016/j.taap.2024.117172
- Published
- 2025 Jan
- Container
- Toxicology and applied pharmacology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.taap.2024.117172,
title = {Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2/ARE pathway in Parkinson's disease.},
author = {Chakkittukandiyil A and Sajini DV and Rymbai E and Sugumar D and Mathew J and Arumugam S and Ramachandran V and Selvaraj D},
year = {2025},
journal = {Toxicology and applied pharmacology},
doi = {10.1016/j.taap.2024.117172},
url = {https://doi.org/10.1016/j.taap.2024.117172}
}RIS
TY - JOUR TI - Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2/ARE pathway in Parkinson's disease. AU - Chakkittukandiyil A AU - Sajini DV AU - Rymbai E AU - Sugumar D AU - Mathew J AU - Arumugam S AU - Ramachandran V AU - Selvaraj D PY - 2025 JO - Toxicology and applied pharmacology DO - 10.1016/j.taap.2024.117172 UR - https://doi.org/10.1016/j.taap.2024.117172 ER -
APA
A, C., DV, S., E, R., D, S., J, M., S, A., V, R., & D, S. (2025). Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2/ARE pathway in Parkinson's disease.. Toxicology and applied pharmacology. https://doi.org/10.1016/j.taap.2024.117172
Source records
- pubmed · retrieved 2026-09-26T13:14:03.710Z
- europe-pmc · retrieved 2026-09-26T13:14:03.712Z